NasdaqGM - Nasdaq Real Time Price USD
Rocket Pharmaceuticals, Inc. (RCKT)
2.5100
-0.1100
(-4.20%)
At close: May 30 at 4:00:01 PM EDT
2.5000
-0.01
(-0.40%)
After hours: May 30 at 7:51:09 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-208,658
-209,724
-194,916
-178,142
-121,163
Investing Cash Flow
38,637
131,706
-98,066
-69,326
18,853
Financing Cash Flow
184,555
185,739
208,401
155,288
37,681
End Cash Position
51,172
164,997
57,276
141,857
234,037
Income Tax Paid Supplemental Data
--
--
--
--
0
Interest Paid Supplemental Data
--
--
--
0
148
Capital Expenditure
-4,191
-5,862
-16,472
-8,619
-7,715
Issuance of Capital Stock
184,555
185,739
208,394
155,335
37,681
Repurchase of Capital Stock
--
0
0
-47
0
Free Cash Flow
-212,849
-215,586
-211,388
-186,761
-128,878
12/31/2021 - 2/18/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NTLA Intellia Therapeutics, Inc.
6.87
-7.79%
SPRO Spero Therapeutics, Inc.
2.5000
+17.37%
PRTA Prothena Corporation plc
4.5900
-2.34%
IFRX InflaRx N.V.
0.8025
-5.60%
IMNN Imunon, Inc.
2.4900
+25.13%
MRUS Merus N.V.
56.07
+1.26%
ALZN Alzamend Neuro, Inc.
3.8300
-29.60%
ORIC ORIC Pharmaceuticals, Inc.
8.17
+2.51%
ITOS iTeos Therapeutics, Inc.
10.02
-0.10%
BCAX Bicara Therapeutics Inc.
9.25
-2.01%